Skip to content

Aloe vera cream and Radiatherapy _ induced skin reaction severity

The survey of aloe vera cream effect on radiatherapy _ induced skin reaction severity in cancer patients in razi hospital Rasht (2007)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138706061118N1
Enrollment
120
Registered
2011-08-09
Start date
2008-02-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: severity of radiation - induced skin reaction. Condition 2: Radiation induced skin reaction. Acute radiodermatitis Other disorders of skin and subcutaneous tissue related to radiation

Interventions

applying a thin layer of Aleo Vera cream on treatment area in case group/no applying any creme or lotion on control group.
Prevention
applying a thin layer of Aleo Vera cream on treatment area in case group/no applying any creme or lotion on control group

Sponsors

Research Affair of Guilan Medical Science University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criterias: patients suffering cancer in head, neck and chest areas;resident in Rasht; having treatment plan with total dose of 40 Gry radiation in at least 25 fractions; having cognitive and mobility ability necessary for AleoVera crean applying on skin under treatment; without any other diseases such as Diabetes, Anemia and Hypertension or skin infectious diseases in treatment area( bacterial cellolitis) or systemic infection (AIDS);without any sign of ecchimosis, or skin lesions in treatment area. Exclusion criteria: considering any sign of sever alergic reaction related to AleoVera cream;improper using of cream by samples according their reports;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of radiation-induced skin reaction in case group will be less than control group. Timepoint: 28 days after initiation of treatment. Method of measurement: observation and completing of RTOG scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojgan Baghaie Lakeh

Guilan medical science university

baghaie@gums.ac.ir+98 13 1322 1185

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026